Integrated DNA Technologies Partners with Elegen to Transform Long DNA Synthesis

Integrated DNA Technologies (IDT), a leader in genomics solutions, has entered into a partnership with Elegen, a next-generation DNA manufacturing firm, to provide IDT customers with early access to Elegen's ENFINIA Plasmid DNA. This joint initiative aims to offer an NGS-verified synthesis service that will deliver 5 kb to 15 kb clonal genes quickly and cost-effectively. This move enhances IDT's already extensive synthetic biology portfolio which includes various synthetic gene products and custom solutions. IDT has bolstered its synthetic biology capabilities in the past year with new product developments and the expansion of its U.S. facility to improve efficiency and throughput. The partnership is poised to supply competitively priced long and complex DNA, facilitating greater innovation in the life sciences. Elegen's CEO, Matthew Hill, emphasizes that this collaboration will broaden access to advanced DNA sequences, boosting research and development. The early access program is now available for IDT customers ahead of the full commercial launch.